These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8348267)

  • 1. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
    Macchioni P; Boiardi L; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
    Br J Rheumatol; 1993 Aug; 32(8):666-70. PubMed ID: 8348267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
    Pountain G; Keogan M; Hazleman B; Brown D
    Br J Rheumatol; 1994 Feb; 33(2):194-5. PubMed ID: 8162492
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
    Pountain GD; Keogan MT; Brown DL; Hazleman BL
    Ann Rheum Dis; 1993 Oct; 52(10):730-3. PubMed ID: 8257209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy.
    Boiardi L; Salvarani C; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Br J Rheumatol; 1996 Jul; 35(7):642-8. PubMed ID: 8670597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.
    Wirsum C; Glaser C; Gutenberger S; Keller B; Unger S; Voll RE; Vach W; Ness T; Warnatz K
    J Clin Immunol; 2016 May; 36(4):406-12. PubMed ID: 26980224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.
    Dasgupta B; Duke O; Timms AM; Pitzalis C; Panayi GS
    Ann Rheum Dis; 1989 Apr; 48(4):307-11. PubMed ID: 2653244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.
    Lopez-Hoyos M; Bartolome-Pacheco MJ; Blanco R; Rodriguez-Valverde V; Martinez-Taboada VM
    Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic approach to the aetiology of giant cell arteritis: depletion of the CD8+ T-lymphocyte subset in relatives of patients with polymyalgia rheumatica and arteritis temporalis.
    Johansen M; Elling P; Elling H; Olsson A
    Clin Exp Rheumatol; 1995; 13(6):745-8. PubMed ID: 8835249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood lymphocyte subsets in polymyalgia rheumatica.
    Uddhammar A; Roos G; Näsman B; Dahlqvist SR
    Clin Rheumatol; 1995 Jan; 14(1):62-7. PubMed ID: 7743746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
    Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
    Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
    Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis.
    Martinez-Taboada VM; Goronzy JJ; Weyand CM
    Clin Immunol Immunopathol; 1996 Jun; 79(3):263-70. PubMed ID: 8635285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.
    Arnold MH; Corrigall VM; Pitzalis C; Panayi GS
    Clin Exp Rheumatol; 1993; 11(6):629-34. PubMed ID: 8299254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.